Robert A. Anderson serves as Executive at bioAffinity Technologies, Inc., where they oversee executive responsibilities. Since joining the company, Robert A. Anderson has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 1, 2024 involved receiving (via award) 33,784 shares valued at $0.
Robert A. Anderson currently holds 163,936 shares of bioAffinity Technologies, Inc. (BIAF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert A. Anderson has been a net neutral trader of BIAF stock. They have purchased $0 and sold $0 worth of shares.
Robert A. Anderson's most recent insider trade was on Jul 1, 2024, when they sold 33,784 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 26, 2024 | BIAF | $75.2K | Option Exercise | 64,848 | $1.16 | Discretionary |
| Jan 1, 2024 | BIAF | $18.7K | Award | 12,668 | $1.48 | Discretionary |
| Oct 1, 2023 | BIAF | $18.7K | Award | 11,867 | $1.58 | Discretionary |
| Jul 1, 2023 | BIAF | $18.7K | Award | 10,245 | $1.83 | Discretionary |
| Apr 15, 2023 | BIAF | $18.7K | Award | 9,920 | $1.89 | Discretionary |
| Jan 1, 2023 | BIAF | $18.8K | Award | 8,227 | $2.28 | Discretionary |
| Aug 31, 2022 | BIAF | $0 | Purchase | 4,081 | $N/A | Discretionary |